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Abstract Cysteine-rich proteins (CRPs) have been shown to be
involved in cell di¡erentiation, transcriptional regulation and the
organisation of the actin cytoskeleton. Thus far, the latter func-
tion has been inferred solely from the in vitro interaction of
CRP1, CRP2, and CRP3 with K-actinin and zyxin. We show
here that puri¢ed, recombinant CRP2 binds directly to F-actin
in vitro in co-sedimentation assays. Using a green £uorescent
protein (GFP)-tagged construct of CRP2 we analysed its local-
isation and dynamics in A7r5 rat smooth muscle cells. CRP2
was associated with the actin cytoskeleton and decorated actin
stress ¢bres in a continuous fashion, unlike the periodic labelling
pattern observed for K-actinin and zyxin, which also accumulate
in focal adhesions. Using live video £uorescence microscopy we
observed the behaviour of GFP-CRP2 during the dynamic re-
arrangement of the actin cytoskeleton in phorbol 12,13-dibuty-
rate-treated A7r5 cells. In contrast to the actin-binding proteins
SM22K and K-actinin, GFP-CRP2 did not translocate into the
podosomes induced by this treatment, but remained preferen-
tially bound to the stress ¢bres, suggesting an actin ¢lament-
stabilising role for CRP2. When fused to the mitochondrial
targeting sequence from the Listeria protein ActA, GFP-
CRP2 was almost completely localised to mitochondria, but
no signi¢cant recruitment of either K-actinin or zyxin could be
observed. Taken together, our results demonstrate that CRP2
can bind to F-actin directly and that the association with the
actin cytoskeleton is independent of K-actinin or zyxin local-
isation in the cell, thus questioning the role of CRP2 as a
regulator of K-actinin function in vivo.
3 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
Cysteine-rich proteins (CRPs) are characterised by the pres-
ence of two LIM domains linked to short glyceine-rich re-
peats. The ¢rst member of the CRP protein family (CRP1)
was identi¢ed by Liebhaber et al., [1] as a widely expressed
and highly conserved CRP with an unusual zinc-¢nger motif.
To date, four CRP family members (CRP1, CRP2, CRP3,
and TLP) have been identi¢ed in vertebrates and several
CRP-like LIM domain proteins have been discovered in ar-
thropods, protozoas and plants (reviewed in [2]). These four
CRP family members share high sequence homologies but
di¡er in their expression patterns. The CRP family proteins
display a dual localisation in the cell and are found both in
the nucleus and along cytoskeletal elements in the cytoplasm
[3^8]. CRP1, 2, and 3 localise to the cell nucleus as well as to
the cytoplasm, where these proteins are associated with the
actin cytoskeleton [7,8], and all three molecules contain a
potential nuclear targeting sequence (KKYGPK) at amino
acid residues 64^69. The dual localisation of CRPs implies
di¡erent roles of the proteins in the di¡erent cellular compart-
ments. In the nucleus, CRPs are implicated in di¡erentiation
processes by acting as cofactors of gene expression [9,10].
Together with the serum response factor (SRF) and GATA
proteins, CRP2 strongly activated the promoters of smooth
muscle speci¢c genes, such as smooth muscle K-actin, h1cal-
ponin and SM22, causing the conversion of pluripotent 10T1/
2 ¢broblasts into smooth muscle cells. CRP2 was thus pro-
posed to act as a bridging molecule, with its N-terminal LIM
domain associating with SRF and its C-terminal LIM domain
binding to GATA4 [10].
Whereas the functions of CRPs inside the nucleus have
been well documented, their role in the cytoplasm remains
largely unclear. CRPs have been shown to bind K-actinin
[5,8] and zyxin [8,11] in vitro. These proteins have been im-
plicated in the control of actin assembly and organisation,
suggesting a role for CRPs in the organisation of the actin
cytoskeleton. The actin association of CRP proteins has there-
fore been speculated to result from K-actinin binding [5]. Re-
cently however, two proteins sharing sequence homologies to
vertebrate CRPs, LimC and LimD, have been identi¢ed in
Dictyostelium discoidum and have been shown to interact di-
rectly with F-actin in vitro [12].
The aim of this study was to shed light on the role of CRPs
in the cytoplasm and to analyse the potential actin binding of
mammalian CRP2 in greater detail.
2. Materials and methods
2.1. Constructs
Full length CRP2 was obtained from IMAGE clone 1923078. All
CRP2 constructs were generated by polymerase chain reaction (PCR)
using this clone as a template.
Standard protocols were used for all cDNA manipulations [13]. For
recombinant expression, CRP2 cDNA was cloned into the vector
pMW 172 [14] via BamHI and EcoRI. PCR primers: FWD: 5P-
GAG AGA ATT CTG GAT CCT TTA TGC CTG TCT GGG
GTG GTG G-3P ; REV: 5P-GAG AGA ATT CCT CGA GTT ACT
GAG CAT GAA CAA GGG CCC-3P. The myc-tagged CRP2 con-
struct was created using FWD: 5P-GAG AGA ATT CTG GAT CCT
TTA TGC CTG TCT GGG GTG GTG G-3P ; REV: 5P-GAG
AGA ATT CCT CGA GTT ACT GAG CAT GAA CAA GGG
CCC-3P ; the resulting cDNA was cloned into the pRK5myc vector
0014-5793 / 03 / $30.00 I 2003 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
doi:10.1016/S0014-5793(03)01451-0
*Corresponding author. Fax: (43)-662-6396140.
E-mail address: markusgrubinger@yahoo.com (M. Grubinger).
Abbreviations: GFP, green £uorescent protein; CRP, cysteine-rich
protein
FEBS 27979 13-1-04 Cyaan Magenta Geel Zwart
FEBS 27979FEBS Letters 557 (2004) 88^92
[15], using BamHI and EcoRI restriction sites. Green £uorescent pro-
tein (GFP)-CRP2 was generated from myc-CRP2, cloning the Bam-
HI^EcoRI cut insert into BglII^EcoRI-digested pEGFPC1 (Clontech,
Heidelberg, Germany). GFP-CRP2-mito was created in two steps:
¢rst a CRP2 cDNA was generated using FWD: 5P-GAG AGA
ATT CTG GAT CCT TTA TGC CTG TCT GGG GTG GTG G-
3P and REV: 5P-GAG AGA ATT CCT GAG CAT GCA CAA GCG
CCC-3P, and cloned into pEGFPC1 via BglII and EcoRI. Second, the
cDNA of the mitochondrially targeting sequence of ActA [16] was
generated by PCR using the GFP-FPPPmito construct (kind gift of
J. Wehland) as template; FWD: 5P-GAG AGA ATT CAC GTT AAT
CCT TGC AAT GTT AGC-3P ; REV: 5P-GAG AGG ATC CTT
AGT TGT TTT TTC TTA ATT G-3P. Resulting cDNA was cloned
in via EcoRI^BamHI. The dsRed-Sm22 construct was a kind gift of
Dominique Brandt (University of Hannover, Germany) and the K-
actinin-GFP construct was a kind gift of J. Wehland (GBF, Braun-
schweig, Germany).
2.2. Expression and puri¢cation of recombinant protein
E. coli strain BL21 was used to express CRP2 protein. Expression
was induced by 1 mM of IPTG for 4 h. Cells were harvested, resus-
pended in 20 ml of an imidazole bu¡er (5 mM imidazole, 30 mM KCl,
1 mM MgCl2, 0.15 mM DTE, pH 7.0) and lysed by passing the
suspension through a French press (SLM Aminco, USA) at 1000
bar. Cell debris was removed by centrifugation in a SS-34 rotor at
25 000Ug for 15 min in a Sorvall RC-5 refrigerated centrifuge. Super-
natant was immediately applied onto a SP-Sepharose cation exchang-
er column (Amersham, Vienna, Austria) and bound proteins were
eluted with a linear gradient ranging from 0 to 1 M NaCl. Fractions
containing substantial amounts of CRP2 were pooled.
Glutathione-S-transferase (GST)-fused CRP2 was expressed in
BL21 and puri¢ed via a GSTrap FF 5 ml column (Amersham, Vien-
na, Austria) according to the manufacturer’s instructions.
2.3. Cell culture, transfection and £uorescence microscopy
A7r5 rat smooth muscle cells were grown in low glucose (1000 mg
l31) Dulbecco’s modi¢ed Eagle’s medium (DMEM) supplemented
with 10% foetal calf serum (FCS; PAA, Linz, Austria), penicillin/
streptomycin (Gibco, Austria) at 37‡C and 5% CO2. B16F1 mouse
melanoma cells were maintained in high glucose (4500 mg l31)
DMEM (Sigma-Aldrich, Vienna, Austria) supplemented with 10%
FCS, penicillin/streptomycin at 37‡C and 5% CO2. For transient ex-
pression, cells were grown in 60 mm plastic culture dishes and trans-
fected using Superfect (Qiagen, Hilden, Germany), essentially as de-
scribed elsewhere [17]. Cells were replated onto 15 mm coverslips 12^
16 h after transfection. Forty-eight hours later cells were prepared for
microscopy. For immuno£uorescence microscopy, cells were washed
twice in PBS (138 mM NaCl, 26 mM KCl, 84 mM Na2HPO4, 14 mM
KH2PO4, pH 7.4), permeabilised for 3 min in 3.7% paraformaldehyde
(PFA)/0.3% Triton X-100 in PBS and ¢xed in 3.7% PFA (Merck,
Darmstadt, Germany). Antibodies: anti-myc (Clontech, Heidelberg,
Germany); anti-K-actinin IgM (Sigma, Vienna, Austria); anti-zyxin
(kind gift of J. Wehland, Braunschweig, Germany). Alexa568-labelled
secondary antibodies (Molecular Probes, Leiden, The Netherlands)
were used.
Fluorescent images were recorded on a Zeiss Axioscope equipped
with an Axiocam driven by the manufacturer’s software package (all
from Zeiss, Vienna, Austria) using a 63U oil immersion lens.
2.4. Live cell video microscopy
Cells were mounted in an open heating chamber (Warner Instru-
ments, Reading, UK) at 37‡C on a Zeiss Axiovert S100TV inverted
microscope (Zeiss, Vienna, Austria) equipped for epi£uorescence and
phase contrast microscopy, using a 63U/NA 1.4 plan apochromatic
objective. Data were acquired with a back-illuminated, cooled CCD
(charged coupled device) camera (Princeton Research Instruments,
NJ, USA) and with computer-controlled shutters (Optilas, Neufahrn,
Germany) in the transmitted and epi£uorescence light paths to min-
imise radiation damage to cells. The camera controller was driven by
IPLab software (Visitron Systems, Eichenau, Germany).
2.5. Actin-binding assays
Pig stomach smooth muscle muscle actin was prepared from acte-
tone powder according to [18]. Co-sedimentation assays were per-
formed in a bu¡er containing 2 mM Tris, 0.1 mM CaCl2, 0.2 mM
ATP, 0.1 mM DTE, 100 mM KCl, 2 mM MgCl2, pH 8.0. Proteins
were mixed, incubated at 25‡C for 30 min and pelleted at 100 000Ug
for 30 min using an air-driven ultracentrifuge (Beckman Instruments).
Supernatant and pellet were separated and the pellet was resuspended
in PBS in the starting volume.
2.6. GST in vitro pull down assays
Glutathione-bound Sepharose beads (Amersham, Vienna, Austria)
were bound to either GSTrap FF puri¢ed GST-CRP2 or equally
obtained GST by overnight incubation of 500 Wl beads in 5 ml protein
solution (3 mg ml31) at 4‡C under rotation. Thirty Wl of the respective
beads was then incubated with K-actinin (0.3 mg ml31) in a Tris bu¡er
(20 mM Tris, 5% glycerol, 0.1% BSA, 50 or 140 mM NaCl) for 2 h at
4‡C under rotation. Beads were washed 5U in the respective bu¡er
without K-actinin, resuspended in 30 Wl sodium dodecyl sulfate (SDS)
mix and heated to 100‡C for 1 min. Resulting samples were subjected
to Western blotting.
2.7. Electrophoresis, Western blotting and immunoprecipitation
Analytical SDS^polyacrylamide gel electrophoresis (PAGE) on 8^
22% gradient polyacrylamide mini-slab gels and Western blotting onto
nitrocellulose (Amersham, Vienna, Austria) were performed as de-
scribed elsewhere [19]. Transferred proteins were visualised using
horseradish peroxidase-coupled secondary antibodies and the ECL
chemiluminescence detection system (Amersham, Vienna, Austria).
Immunoprecipitations were performed from cell lysates of B16F1 cells
expressing GFP-tagged K-actinin and myc-tagged CRP2 essentially as
described earlier [25] with modi¢cations in the bu¡er (20 mM Tris pH
7.0, 140 mM NaCl, 5 mM KCl, 0.5% Triton X-100, 5% glycerol, 0.1
mM phenylmethylsulfonyl £uoride, 0.67 Wg ml31 pepstatin, 1.67 Wg
ml31 leupeptin). Tag speci¢c antibodies were obtained from Clontech
(Heidelberg, Germany).
2.8. Reagents
Phorbol 12,13-dibutyrate (PDBu) was purchased from Sigma
(Vienna, Austria).
3. Results and discussion
Fig. 1 shows the CRP2 mutants constructed for this study.
For in vitro actin-binding assays we constructed cDNA plas-
mid for expression and puri¢cation of recombinant bacterial
CRP2 and coding exclusively for the CRP2 sequence, in ad-
dition to a fusion mutant (GST-CRP2) for in vitro pull down
assays. Further, we generated GFP-CRP2 and myc-CRP2
constructs, and the mutant GFP-CRP2-mito, in which the
mitochondrial targeting sequence of ActA (Listeria monocyto-
Fig. 1. CRP2 constructs used in this study. CRP2 contains two
LIM domains followed by short glycine-rich repeats (GRR). Myc
and GFP moieties were fused to the N-terminal end of the CRP
molecule. For GFP-CRP2-mito, the mitochondrial targeting se-
quence of ActA (L. monocytogenes) was fused to the C-terminus of
GFP-CRP2.
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genes) was fused to the C-terminus of GFP-CRP2, for expres-
sion in mammalian cells.
When myc-CRP2 was transfected into cultured A7r5 vas-
cular smooth muscle cells it localised to the stress ¢bre bun-
dles continuously. In contrast to K-actinin-GFP, which local-
ised periodically along the actin stress ¢bres as well as in focal
adhesions (Fig. 2A^C). GFP-tagged CRP2 localised identi-
cally with myc-CRP2, also with a conspicuous absence from
the stress ¢bre ends, where zyxin preferentially was found
(Fig. 2D^F).
This di¡erence in localisation between these proteins, for-
merly identi¢ed as binding partners, raised the concern that
N-terminal fusion of CRP2 may interfere with its interaction
with K-actinin. To test this possibility we employed pull down
in vitro assays with CRP2 fused to GST at the N-terminus. As
seen in Fig. 3 K-actinin readily co-sedimented with GST-
CRP2 bound to glutathione beads (lanes 1 and 2), but not
with GST alone (lanes 3 and 4). Notably, the interaction with
K-actinin was signi¢cantly reduced under physiological salt
conditions (140 mM NaCl) as compared to the low salt con-
ditions in 50 mM NaCl, suggesting that the interaction could
be of ionic nature. Taken together, the N-terminal fusion of
GFP to CRP appears not to a¡ect the interaction with K-
actinin and should thus not in£uence the subcellular localisa-
tion of the protein. However, the observed in vitro interaction
between GST-CRP2 and K-actinin could not be con¢rmed by
co-immunoprecipitation experiments using ectopically ex-
pressed GFP-tagged K-actinin and myc-tagged CRP2 under
physiological conditions (data not shown).
These results suggested that the association of CRP2 with
the actin cytoskeleton may be independent of the interaction
with the two binding partners K-actinin and zyxin. To further
investigate this possibility we employed high speed actin co-
sedimentation assays. Puri¢ed recombinant CRP2 was centri-
fuged at 100 000Ug in the presence or absence of pure smooth
muscle actin, and supernatant and pellet were analysed on
SDS^PAGE gels. As shown in Fig. 4, CRP2 was found en-
riched in the pellet together with F-actin, whereas CRP2 alone
did not sediment. This experiment clearly demonstrated that
CRP2 binds directly to F-actin in vitro in the absence of other
actin-binding proteins.
It thus seems that zyxin and K-actinin are dispensable for
the recruitment of CRP2 to the actin cytoskeleton. However,
one cannot exclude a possible in£uence of the localisation of
CRP2 on the binding characteristics of K-actinin and zyxin.
To address this question we fused the mitochondrial targeting
sequence of the Listeria protein ActA to GFP-CRP2 to induce
subcellular mislocalisation. The fusion caused an almost com-
Fig. 2. Subcellular localisation of CRP2 in A7r5 cells. In contrast to
the homogeneous decoration of actin ¢laments by myc-CRP2 (B),
K-actinin-GFP localised periodically along the actin stress ¢bres and
was strongly enriched at focal adhesions (A). Image CP shows a de-
tail of the merged image in C, visualising the only partially overlap-
ping patterns of K-actinin-GFP and myc-CRP2 along the actin cyto-
skeleton. Cells were double-transfected with K-actinin-GFP (A) and
myc-CRP2 (B), ¢xed and stained with anti-myc antibody and
Alexa568-conjugated secondary antibody. Scale bar, 20 Wm. D^F:
Zyxin was found associated with focal adhesions, whereas GFP-
CRP2 localised exclusively along the actin stress ¢bres. A7r5 cells
expressing GFP-CRP2 were ¢xed and stained with an anti-zyxin
antibody and an Alexa568-conjugated secondary antibody. Scale
bar, 5 Wm.
Fig. 3. In vitro pull down assay with K-actinin and GST-CRP2.
GST-CRP2 (lanes 1 and 2), but not GST alone (lanes 3 and 4), co-
precipitates K-actinin. The interaction is sensitive to increasing ionic
concentrations. Lanes 1 and 3: 50 mM NaCl; lanes 2 and 4: 140
mM NaCl. Western blot probed with anti-K-actinin (A) or anti-
GST (B) antibody. For Western blot B, samples from A were di-
luted 1:10.
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plete alteration in the localisation of transiently transfected
CRP2 in A7r5 cells, and the GFP signal was now concen-
trated exclusively at the mitochondrial surface. However,
this mislocalisation of CRP2 did not impact on the localisa-
tion of K-actinin, which showed its normal, actin- and focal
adhesion-associated subcellular distribution (Fig. 5). Likewise,
the localisation of zyxin was unchanged in GFP-CRP2-mito-
expressing cells (not shown). Taken together, these data sup-
port the autonomous, and K-actinin and zyxin-independent
actin binding and cytoskeleton associating properties of
CRP2.
If CRP2 is not involved in regulating the function of cyto-
skeleton organising components as a ‘secondary modulating
component’, what other physiological role could then be as-
cribed to cytoplasmic CRP2? It has been shown recently that
treatment of A7r5 cells with the phorbol ester PDBu induces
the rapid remodeling of the actin cytoskeleton and the forma-
tion of podosomes at the cell periphery [20,21], and that dif-
ferent actin-binding proteins segregated di¡erentially during
this process [22]. For example, SM22 and K-actinin were rap-
idly translocated to podosomes, whereas overexpression of
calponin stabilised actin ¢laments in living cells and inhibited
podosome induction in response to PDBu [22]. In GFP-
CRP2-transfected cells treated with 1 WM PDBu for 20 min,
the molecule remained associated with actin ¢lament bundles
despite the formation of peripheral podosomes (Fig. 6). The
turnover of the actin cytoskeleton appeared delayed and
translocation of detectable amounts of GFP-CRP2 to podo-
somes was only seen after prolonged exposure to PDBu by
which time most of the stress ¢bres had disassembled (not
shown).
In summary, our results identify mammalian CRP2 as an
F-actin-binding molecule which can associate autonomously
with the actin cytoskeleton. This ¢nding is well supported by a
recent report from the Noegel lab, who identi¢ed direct actin-
binding capacity in several CRP orthologs from Dictyostelium
discoideum [12]. In light of these results the role of CRP2 as a
potential regulator of K-actinin (and zyxin?) function in vivo
should be reconsidered.
4. Conclusion and hypothesis
CRP2 functions and localises independently of K-actinin
and zyxin, and may not play a signi¢cant role in the regula-
tion of the cellular function of these cytoskeletal components.
CRP2 binds directly to actin and, similar to zyxin, another
LIM domain-containing protein may shuttle from the cyto-
plasm to the nucleus. There, CRP2 can act as a cofactor of
SRF, and is involved in enhancing the expression of smooth
Fig. 4. Co-sedimentation of F-actin and CRP2. Puri¢ed, recombi-
nant CRP2 (2 mg ml31) was incubated with (lanes 3 and 4) or with-
out (lanes 1 and 2) F-actin (2 mg ml31) and centrifuged at
100 000Ug. Subsequently, supernatants (S) and pellets (P) were sep-
arated and subjected to PAGE. CRP2 bound to F-actin as indicated
by its presence in the actin pellet after centrifugation (lane 4).
Fig. 5. GFP-CRP2-mito does not recruit endogenous K-actinin.
GFP-CRP2 fused to the mitochondrial targeting sequence of ActA
localises to the mitochondrial surface. The subcellular distribution
of K-actinin at actin ¢bres and in focal adhesion, however, is unaf-
fected. A7r5 cells transfected with GFP-CRP2-mito were ¢xed, and
stained with an anti-K-actinin antibody and Alexa568-conjugated
secondary antibody. Scale bar, 20 Wm.
Fig. 6. CRP2 during F-actin remodelling. Treatment of A7r5 cells
with 1 WM PDBu causes the rapid rearrangement of the actin cyto-
skeleton and leads to the formation of podosomes at the cell periph-
ery. Selected frames of a movie sequence of an A7r5 cell expressing
GFP-CRP2 and dsRed-SM22 are shown. While dsRed-SM22 is rap-
idly translocated and incorporated into newly forming podosomes,
GFP-CRP2 remains bound to the actin stress ¢bres. Scale bar, 20
Wm.
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muscle speci¢c gene products like calponin, SM22K or smooth
muscle K-actin. Results from the Treisman lab [23,24] suggest
that SRF activation requires decreased G-actin levels and that
SRF-controlled expression of muscle speci¢c cytoskeletal
components may be a method to relay morphological changes
in the cell. The data argue for a mechanism capable of sensing
the status of actin polymerisation in the cytoplasm, and re-
sponding by activation of SRF-dependent gene expression. It
is tempting to speculate that CRP2 could be a part of such a
putative ‘sensor’ complex that is sequestered on actin and has
the ability to translocate from the cytoplasm to the nucleus, to
signal increased activity of SRF. Future studies should ad-
dress the potential involvement of CRP molecules in regulat-
ing SRF in response to alterations in the balance between G-
and F-actin in the cell.
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